Does LISOCABTAGENE MARALEUCEL Cause Sepsis? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Sepsis have been filed in association with LISOCABTAGENE MARALEUCEL (BREYANZI). This represents 1.5% of all adverse event reports for LISOCABTAGENE MARALEUCEL.
11
Reports of Sepsis with LISOCABTAGENE MARALEUCEL
1.5%
of all LISOCABTAGENE MARALEUCEL reports
6
Deaths
6
Hospitalizations
How Dangerous Is Sepsis From LISOCABTAGENE MARALEUCEL?
Of the 11 reports, 6 (54.5%) resulted in death, 6 (54.5%) required hospitalization, and 3 (27.3%) were considered life-threatening.
Is Sepsis Listed in the Official Label?
Yes, Sepsis is listed as a known adverse reaction in the official FDA drug label for LISOCABTAGENE MARALEUCEL.
What Other Side Effects Does LISOCABTAGENE MARALEUCEL Cause?
Cytokine release syndrome (315)
Immune effector cell-associated neurotoxicity syndrome (129)
Neurotoxicity (101)
Pyrexia (47)
Fatigue (38)
Hypotension (38)
Febrile neutropenia (28)
Confusional state (27)
Death (25)
Lymphocyte adoptive therapy (25)
What Other Drugs Cause Sepsis?
RITUXIMAB (4,043)
CYCLOPHOSPHAMIDE (4,041)
METHOTREXATE (3,933)
ADALIMUMAB (3,169)
DEXAMETHASONE (3,150)
LENALIDOMIDE (2,956)
VINCRISTINE (2,791)
DOXORUBICIN (2,740)
PREDNISONE (2,634)
PREDNISOLONE (2,281)
Which LISOCABTAGENE MARALEUCEL Alternatives Have Lower Sepsis Risk?
LISOCABTAGENE MARALEUCEL vs LITHIUM
LISOCABTAGENE MARALEUCEL vs LIXISENATIDE
LISOCABTAGENE MARALEUCEL vs LOBAPLATIN
LISOCABTAGENE MARALEUCEL vs LOFEXIDINE
LISOCABTAGENE MARALEUCEL vs LOMITAPIDE